Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to
Tag: Obesity
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but
The big decisions you’ll need to make once on new weight loss drugs
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan Mcdermid
Cramer’s rapid-fire look at UPS, Walmart, GM, Boeing, Novo Nordisk, Tesla
United Parcel Service — The stock continued lower Wednesday, one day after falling more than 8% on a disappointing 2024 revenue outlook
Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor,
Analysts raising forecasts for blockbuster obesity drugs
As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be blockbusters, with some of the highest
Ozempic, Wegovy may curb drinking, smoking: What we know
An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023. Jaap Arriens | Nurphoto
Big pharma blockbuster obesity drug battle is headed for $100 billion
Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are
Medical device stocks could still be a good buy, analysts say
Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won’t hurt the demand for insulin pumps and continuous
Should airlines weigh passengers? It’s for safety, say airlines
Starting Monday, passengers flying on Korean Air may be asked to step on a scale before boarding their flight. The exercise, which
No More Posts Available.
No more pages to load.